Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. was established in 2009. At present, the company has two wholly-owned subsidiaries, Shenzhen Jianxiang Biopharmaceutical Co., LTD and Hubei Jianxiang Biopharmaceutical Co., LTD. The company has established a research and development technology platform of natural product precursor drugs and polypeptide and protein drug slow-release preparations with known targets in China. The company has a 1000m2 R&D center in the bio-incubator of Shenzhen High-tech Zone; R&d center has a complete drug research and development system, equipped with advanced instruments and equipment, such as high performance liquid chromatograph, preparation chromatograph, mass spectrometer, gas chromatograph, ion chromatograph, and slow release microspheres pilot production line. At the same time, in Pingshan New District...
Nanjing Xingyin Pharmaceutical Research Co., Ltd. was established in 2000, focusing on clinical new drug research and development. Since the establishment of the company, its self-developed drugs include zinc gluconate nasal spray (Xingrelin), triamcinolone acetonide nasal spray (Xingrec), Gegen decoction mixture, compound codeine phosphate oral solution, Zalaiplon tablets, etc. These drugs are widely used in clinical practice, and their exact efficacy is highly respected by doctors and patients. At the same time, the company actively declared patented technology, has applied for 17 patents such as Gegen Tang mixture manufacturing process, and obtained 6 authorized patents. In recent years, Nanjing Xingyin Drug Research Co., Ltd. involved in the development of clinical new drugs including antihypertensive drugs, hypoglycemic drugs, immune system drugs, ophthalmic...
